Healthcare Sector

MRKR

Market Tracker

  • MRKR (Selected)

    Marker Therapeutics, Inc.

MRKR Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

MRKR Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

MRKR Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

MRKR Major Holders

Name Pct Held Shares Total
Vanguard Extended Market Index Fund 0.99% 87.14k 418.26k
Vanguard Total Stock Market Index Fund 0.86% 75.95k 364.56k
Fidelity Extended Market Index Fund 0.43% 37.57k 180.33k
iShares Core S&P Total U.S. Stock Market ETF 0.12% 10.6k 50.87k
Fidelity Total Market Index Fund 0.10% 8.95k 42.96k
Vanguard Institutional Index-Inst Total Stock Market Ind 0.06% 5.69k 27.31k
Fidelity Series Total Market Index Fund 0.06% 5.6k 26.9k
Vanguard Balanced Index Fund 0.06% 5.5k 26.38k
Fidelity NASDAQ Composite Index Fund 0.03% 2.34k 11.24k
USAA Mutual Fd Tr-Extended Market Index Fd 0.01% 645 3.1k

MRKR News

  • Marker Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

    05/15 04:15 pm

    GlobeNewswire Inc.

    Read more
  • Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies 

    04/08 07:00 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results

    03/25 05:45 pm

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

    03/22 12:30 pm

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601

    01/22 08:30 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization

    01/08 09:24 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024”

    12/21 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates

    11/09 06:00 pm

    GlobeNewswire Inc.

    Read more
  • Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    09/11 01:38 pm

    Benzinga

    Read more
  • Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse

    09/11 07:00 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

    08/30 08:00 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

    08/14 04:30 pm

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Reports Non-Clinical Proof-of-Concept Data and Update on Clinical Readiness for the MT-401 Off-the-Shelf Program

    08/07 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session

    07/31 03:30 pm

    Benzinga

    Read more
  • Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    07/24 02:54 pm

    Benzinga

    Read more
  • Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    07/10 12:34 pm

    Benzinga

    Read more
  • European Medicines Agency Grants Orphan Drug Designation for MT-401 developed by Marker Therapeutics for the Treatment of AML Patients

    07/10 07:00 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Reports MT-401 Non-Clinical Data in AML Cells after Hypomethylating Agent Administration

    06/26 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why Motorcar Parts of America Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    06/13 12:47 pm

    Benzinga

    Read more
  • Nasdaq Gains 1%; US Budget Deficit Widens In May

    06/12 02:54 pm

    Benzinga

    Read more
  • Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    06/12 01:03 pm

    Benzinga

    Read more
  • Crude Oil Drops Sharply; Chinook Therapeutics Shares Spike Higher

    06/12 12:05 pm

    Benzinga

    Read more
  • Marker Therapeutics Announces First Lymphoma Patient Treated with MT-601 in Phase 1 Clinical Trial

    06/12 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    06/09 12:49 pm

    Benzinga

    Read more
  • Why Mallinckrodt Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket

    06/05 08:10 am

    Benzinga

    Read more
  • Utilizing Fundamental Analysis for Your Penny Stocks? 3 Tips 

    06/01 06:00 am

    PennyStocks

    Read more
  • Crude Oil Down 2%; Donaldson Shares Drop Following Q3 Results

    05/31 02:39 pm

    Benzinga

    Read more
  • Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    05/31 01:01 pm

    Benzinga

    Read more
  • Nasdaq Down 100 Points; Advance Auto Parts Earnings Miss Views

    05/31 12:06 pm

    Benzinga

    Read more
  • Marker Therapeutics Reports Pre-Clinical Data of its MT-601 MultiTAA-Specific T Cell Product Candidate in Lymphoma Cells

    05/31 06:30 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics Appoints Monic Stuart, M.D., as Chief Medical Officer

    05/08 07:30 am

    GlobeNewswire Inc.

    Read more
  • 7 Low Float Penny Stocks To Watch After SNTG Stock Explodes

    05/01 12:10 pm

    PennyStocks

    Read more
  • Marker Therapeutics Announces Comprehensive Non-Dilutive Agreement With CellReady™

    05/01 07:30 am

    GlobeNewswire Inc.

    Read more
  • Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    04/17 01:27 pm

    Benzinga

    Read more
  • Marker Therapeutics Reports Fiscal Year 2022 Corporate and Financial Results

    03/22 08:10 am

    GlobeNewswire Inc.

    Read more
  • Marker Therapeutics and Lincoln Park Capital Enter into a Common Stock Purchase Agreement for up to $25 Million

    12/13 08:00 am

    GlobeNewswire Inc.

    Read more
  • Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session

    11/16 03:02 pm

    Benzinga

    Read more
  • MARKER THERAPEUTICS, INC. (MRKR) Reports Q3 Loss, Tops Revenue Estimates

    11/10 06:35 pm

    Zacks Investment Research

    Read more
  • Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday

    10/18 05:27 am

    Benzinga

    Read more
  • Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session

    10/17 12:23 pm

    Benzinga

    Read more
  • Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday

    10/17 05:21 am

    Benzinga

    Read more
  • 3 Hot Penny Stocks To Buy For Under $1 Right Now

    10/14 12:53 pm

    PennyStocks

    Read more
  • Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday

    09/30 04:49 am

    Benzinga

    Read more
  • Why Sunlight Financial Shares Are Trading Lower By 59%, Here Are 54 Stocks Moving In Thursday's Mid-Day Session

    09/29 12:45 pm

    Benzinga

    Read more
  • Marker Therapeutics Awarded $2 Million Grant from U.S. FDA to Support Marker’s Phase 2 ARTEMIS Trial of MT-401 in Post-Transplant AML

    09/13 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday

    09/09 04:13 am

    Benzinga

    Read more
  • Marker Therapeutics to Participate in Cantor Fitzgerald Cell and Genetic Medicines Conference

    09/08 07:00 am

    GlobeNewswire Inc.

    Read more
  • Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket

    08/22 07:13 am

    Benzinga

    Read more
  • Marker Therapeutics Reports Q2 2022 Operating and Financial Results

    08/11 04:22 pm

    GlobeNewswire Inc.

    Read more
  • Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session

    08/08 12:49 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: